GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » EV-to-EBIT

Medlive Technology Co (HKSE:02192) EV-to-EBIT : 5.04 (As of May. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medlive Technology Co's Enterprise Value is HK$1,398.2 Mil. Medlive Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$277.3 Mil. Therefore, Medlive Technology Co's EV-to-EBIT for today is 5.04.

The historical rank and industry rank for Medlive Technology Co's EV-to-EBIT or its related term are showing as below:

HKSE:02192' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.79   Med: 12.97   Max: 247.82
Current: 4.98

During the past 6 years, the highest EV-to-EBIT of Medlive Technology Co was 247.82. The lowest was -7.79. And the median was 12.97.

HKSE:02192's EV-to-EBIT is ranked better than
83.75% of 80 companies
in the Medical Distribution industry
Industry Median: 13.59 vs HKSE:02192: 4.98

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medlive Technology Co's Enterprise Value for the quarter that ended in Dec. 2023 was HK$1,412.3 Mil. Medlive Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$277.3 Mil. Medlive Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 19.63%.


Medlive Technology Co EV-to-EBIT Historical Data

The historical data trend for Medlive Technology Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co EV-to-EBIT Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - 170.31 9.62 5.09

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 170.31 - 9.62 - 5.09

Competitive Comparison of Medlive Technology Co's EV-to-EBIT

For the Medical Distribution subindustry, Medlive Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's EV-to-EBIT falls into.



Medlive Technology Co EV-to-EBIT Calculation

Medlive Technology Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1398.180/277.265
=5.04

Medlive Technology Co's current Enterprise Value is HK$1,398.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$277.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medlive Technology Co  (HKSE:02192) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medlive Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=277.265/1412.31924
=19.63 %

Medlive Technology Co's Enterprise Value for the quarter that ended in Dec. 2023 was HK$1,412.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$277.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medlive Technology Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines